Gendy, Marie N. S.
Lagzdins, Dina
Schaman, Jessika
Le Foll, Bernard
Article History
Received: 24 September 2019
Accepted: 19 March 2020
First Online: 26 May 2020
Competing interests
: Dr. Le Foll has/will received some in-kind donation of cannabis product from Canopy and Aurora and medication donation from Pfizer and Bioprojet and was provided a coil for TMS study from Brainsway. Dr. Le Foll has/will perform research with industry funding obtained from Canopy, Bioprojet, ACS and Alkermes. Dr. Le Foll has received in kind donations of nabiximols from GW Pharma for past studies funded by CIHR and NIH. The other authors declared no conflict of interest.